X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Acquiring Cigna will give Anthem a way to vie for business against Blue Cross & Blue Shield Association plans around the country, said Morgan Kendrick, Anthem’s president of national accounts. (Photo: iStock)

Anthem Inc. fired back against U.S. claims that the health insurer’s planned $48 billion takeover of rival Cigna Corp. will undermine competition, with an Anthem executive testifying that the company plans to use Cigna to compete in new markets.

Acquiring Cigna will give Anthem a way to vie for business against Blue Cross & Blue Shield Association plans around the country, said Morgan Kendrick, Anthem’s president of national accounts. As a member of the association, Anthem is restricted in competing against other Blue Cross Blue Shield plans, but Kendrick testified Tuesday that Cigna won’t be.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO
Live Chat

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.